Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
August 04, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
August 02, 2023 07:30 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported...
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
July 11, 2023 09:23 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will...
Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
May 24, 2023 08:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology Reports First Quarter 2023 Financial Results
May 02, 2023 06:30 ET
|
Nautilus Biotechnology Inc.
SEATTLE, May 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
April 18, 2023 16:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will...
Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
March 23, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology Announces “First Access Challenge” Winners
March 07, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 23, 2023 06:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference
February 21, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...